AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT

AC Immune S.A. Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
27.31M 14.8M 3.94M n/a
Cost of Revenue
n/a 54.61M 60.34M 62.28M
Gross Profit
27.31M -39.8M -56.4M -62.28M
Operating Income
-52.38M -53.62M -70.85M -79.01M
Interest Income
3.2M 1.04M 69K 6.49M
Pretax Income
-50.91M -54.22M -70.74M -72.99M
Net Income
-50.92M -54.23M -70.75M -73M
Selling & General & Admin
11.43M 10.58M 15.79M 10.88M
Research & Development
62.57M 54.61M 60.34M 62.28M
Other Expenses
5.68M -51.36M -1.34M 5.85M
Operating Expenses
79.69M 13.82M 74.78M 79.01M
Interest Expense
133K 176K 355K 581K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
79.69M 68.42M 74.78M 79.01M
Income Tax Expense
3K 10K 13K 3K
Shares Outstanding (Basic)
99.69M 84.69M 83.55M 74.95M
Shares Outstanding (Diluted)
99.69M 84.69M 83.55M 74.95M
EPS (Basic)
-0.51 -0.64 -0.85 -0.97
EPS (Diluted)
-0.51 -0.64 -0.85 -0.97
EBITDA
-48.62M -51.83M -69.05M -77.11M
EBIT
-50.78M -54.05M -70.39M -79.01M
Depreciation & Amortization
2.16M 2.21M 2.36M 1.9M